Boston Scientific (BSX)

R&D Expenses

$2.15B

TTM · Period ending: · USD

BSX logo

BSX R&D Expenses

Latest reported$2.15B
BSX TTM R&D Expenses ($0.00 → $2.15B)
High-resolution chart · PNG

BSX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
228,000,000
206,000,000
199,000,000
197,000,000
197,000,000
197,000,000
197,000,000
885,200,000
886,900,000
886,500,000
882,100,000
216,500,000
210,100,000
202,500,000
191,600,000
118,000,000
105,000,000
92,700,000
84,800,000
84,800,000
72,000,000
59,700,000
49,700,000
57,000,000
46,700,000
37,900,000
29,600,000
22,300,000
15,100,000
7,500,000
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.